
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $638.1M | $573.2M | $737.7M | $782.3M | $692.6M | |
Revenue Growth (YoY) | -37.28% | -10.17% | 28.71% | 6.04% | -11.47% | |
Cost of Revenues | $660.3M | $551.1M | $645.9M | $667.7M | $590.9M | |
Gross Profit | -$22.3M | $22M | $91.8M | $114.6M | $101.7M | |
Gross Profit Margin | -3.49% | 3.84% | 12.45% | 14.65% | 14.68% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $94.1M | $83.7M | $96M | $94.2M | $95M | |
Other Inc / (Exp) | -$404.6M | -$2.5M | $3.3M | $849K | -$23M | |
Operating Expenses | $93.6M | $82.7M | $88.9M | $91.5M | $78.8M | |
Operating Income | -$115.8M | -$60.6M | $2.9M | $23.2M | $22.9M | |
Net Interest Expenses | $13.9M | $10.2M | $10.3M | $8.2M | $7.7M | |
EBT. Incl. Unusual Items | -$534.3M | -$73.3M | -$4.1M | $15.8M | -$7.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$65.9M | -$9.3M | $5.5M | $2.9M | $3.4M | |
Net Income to Company | -$468.4M | -$64M | -$9.5M | $12.9M | -$11.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$468.4M | -$64M | -$9.5M | $12.9M | -$11.3M | |
Basic EPS (Cont. Ops) | -$7.83 | -$1.06 | -$0.15 | $0.20 | -$0.18 | |
Diluted EPS (Cont. Ops) | -$7.83 | -$1.06 | -$0.15 | $0.20 | -$0.18 | |
Weighted Average Basic Share | $59.8M | $60.3M | $61.6M | $62.7M | $62M | |
Weighted Average Diluted Share | $59.8M | $60.3M | $61.6M | $63.2M | $62M | |
EBITDA | -$421.5M | $17.7M | $73.8M | $86.2M | $55.7M | |
EBIT | -$520.1M | -$63M | $6.5M | $25.4M | $949K | |
Revenue (Reported) | $638.1M | $573.2M | $737.7M | $782.3M | $692.6M | |
Operating Income (Reported) | -$115.8M | -$60.6M | $2.9M | $23.2M | $22.9M | |
Operating Income (Adjusted) | -$520.1M | -$63M | $6.5M | $25.4M | $949K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $125.6M | $164M | $196.2M | $167.3M | $159.9M | |
Revenue Growth (YoY) | -42.84% | 30.62% | 19.6% | -14.75% | -4.38% | |
Cost of Revenues | $123.8M | $144.4M | $166M | $146.1M | $134.7M | |
Gross Profit | $1.8M | $19.6M | $30.2M | $21.1M | $25.2M | |
Gross Profit Margin | 1.4% | 11.96% | 15.4% | 12.63% | 15.78% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $21.2M | $23.8M | $24M | $22.5M | $22.5M | |
Other Inc / (Exp) | $3.3M | $1M | $276K | -$10.1M | $138K | |
Operating Expenses | $20.9M | $24M | $24.3M | $22.3M | $19.6M | |
Operating Income | -$19.1M | -$4.3M | $5.9M | -$1.2M | $5.6M | |
Net Interest Expenses | $2.3M | $2.7M | $2.4M | $2.1M | $1.6M | |
EBT. Incl. Unusual Items | -$18.1M | -$6M | $3.8M | -$13.4M | $4.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.3M | $3.4M | $1.6M | $24K | $1M | |
Net Income to Company | -$15.8M | -$9.4M | $2.2M | -$13.4M | $3.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$15.8M | -$9.4M | $2.2M | -$13.4M | $3.2M | |
Basic EPS (Cont. Ops) | -$0.26 | -$0.16 | $0.03 | -$0.21 | $0.05 | |
Diluted EPS (Cont. Ops) | -$0.26 | -$0.16 | $0.03 | -$0.21 | $0.05 | |
Weighted Average Basic Share | $60.1M | $60.5M | $62.8M | $62.5M | $60.2M | |
Weighted Average Diluted Share | $60.1M | $60.5M | $63.1M | $62.5M | $60.2M | |
EBITDA | $5.7M | $14.5M | $21.4M | $2.9M | $17.8M | |
EBIT | -$15.8M | -$3.3M | $6.2M | -$11.2M | $5.8M | |
Revenue (Reported) | $125.6M | $164M | $196.2M | $167.3M | $159.9M | |
Operating Income (Reported) | -$19.1M | -$4.3M | $5.9M | -$1.2M | $5.6M | |
Operating Income (Adjusted) | -$15.8M | -$3.3M | $6.2M | -$11.2M | $5.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $544M | $611.6M | $769.9M | $753.3M | $685.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $560.2M | $571.7M | $667.5M | $647.8M | $579.5M | |
Gross Profit | -$16.2M | $39.9M | $102.4M | $105.5M | $105.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $89.2M | $86.3M | $96.2M | $92.7M | $95M | |
Other Inc / (Exp) | $9.2M | -$4.8M | $2.6M | -$9.5M | -$12.8M | |
Operating Expenses | $88.2M | $85.7M | $89.3M | $89.4M | $76.1M | |
Operating Income | -$104.4M | -$45.9M | $13.1M | $16.1M | $29.7M | |
Net Interest Expenses | $12.7M | $10.5M | $10M | $7.9M | $7.2M | |
EBT. Incl. Unusual Items | -$107.9M | -$61.2M | $5.7M | -$1.3M | $9.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$28.8M | -$3.6M | $3.6M | $1.4M | $4.4M | |
Net Income to Company | -$79.2M | -$57.6M | $2M | -$2.6M | $5.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$79.2M | -$57.6M | $2M | -$2.6M | $5.3M | |
Basic EPS (Cont. Ops) | -$1.31 | -$0.96 | $0.03 | -$0.04 | $0.08 | |
Diluted EPS (Cont. Ops) | -$1.31 | -$0.96 | $0.03 | -$0.04 | $0.08 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$1.2M | $26.5M | $80.7M | $67.7M | $70.5M | |
EBIT | -$94.8M | -$50.5M | $16M | $8M | $18M | |
Revenue (Reported) | $544M | $611.6M | $769.9M | $753.3M | $685.3M | |
Operating Income (Reported) | -$104.4M | -$45.9M | $13.1M | $16.1M | $29.7M | |
Operating Income (Adjusted) | -$94.8M | -$50.5M | $16M | $8M | $18M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $125.6M | $164M | $196.2M | $167.3M | $159.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $123.8M | $144.4M | $166M | $146.1M | $134.7M | |
Gross Profit | $1.8M | $19.6M | $30.2M | $21.1M | $25.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $21.2M | $23.8M | $24M | $22.5M | $22.5M | |
Other Inc / (Exp) | $3.3M | $1M | $276K | -$10.1M | $138K | |
Operating Expenses | $20.9M | $24M | $24.3M | $22.3M | $19.6M | |
Operating Income | -$19.1M | -$4.3M | $5.9M | -$1.2M | $5.6M | |
Net Interest Expenses | $2.3M | $2.7M | $2.4M | $2.1M | $1.6M | |
EBT. Incl. Unusual Items | -$18.1M | -$6M | $3.8M | -$13.4M | $4.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.3M | $3.4M | $1.6M | $24K | $1M | |
Net Income to Company | -$15.8M | -$9.4M | $2.2M | -$13.4M | $3.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$15.8M | -$9.4M | $2.2M | -$13.4M | $3.2M | |
Basic EPS (Cont. Ops) | -$0.26 | -$0.16 | $0.03 | -$0.21 | $0.05 | |
Diluted EPS (Cont. Ops) | -$0.26 | -$0.16 | $0.03 | -$0.21 | $0.05 | |
Weighted Average Basic Share | $60.1M | $60.5M | $62.8M | $62.5M | $60.2M | |
Weighted Average Diluted Share | $60.1M | $60.5M | $63.1M | $62.5M | $60.2M | |
EBITDA | $5.7M | $14.5M | $21.4M | $2.9M | $17.8M | |
EBIT | -$15.8M | -$3.3M | $6.2M | -$11.2M | $5.8M | |
Revenue (Reported) | $125.6M | $164M | $196.2M | $167.3M | $159.9M | |
Operating Income (Reported) | -$19.1M | -$4.3M | $5.9M | -$1.2M | $5.6M | |
Operating Income (Adjusted) | -$15.8M | -$3.3M | $6.2M | -$11.2M | $5.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $72M | $52.9M | $42M | $47.1M | $65.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $109.3M | $116.4M | $145.5M | $128.4M | $128.2M | |
Inventory | $170.4M | $168.6M | $182.7M | $202M | $214.8M | |
Prepaid Expenses | $18.1M | -- | -- | -- | -- | |
Other Current Assets | -- | $19.2M | $19.3M | $35.6M | $23.7M | |
Total Current Assets | $423.6M | $426.7M | $462.8M | $488M | $498.2M | |
Property Plant And Equipment | $416.7M | $364M | $326.9M | $302.4M | $286.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $76.5M | $76.4M | $79.3M | $79.9M | $69.7M | |
Other Intangibles | $205.7M | $185.7M | $169.8M | $153M | $125.9M | |
Other Long-Term Assets | $5.6M | $5M | $4.7M | $2.7M | $3.1M | |
Total Assets | $1.2B | $1.1B | $1.1B | $1B | $1B | |
Accounts Payable | $46.4M | $63.3M | $73.3M | $67.5M | $57.7M | |
Accrued Expenses | $18.7M | $17.4M | $13.5M | $15M | $13.3M | |
Current Portion Of Long-Term Debt | $17.8M | $18.3M | $17.8M | $627K | $633K | |
Current Portion Of Capital Lease Obligations | $7.6M | $6.5M | $6.1M | $6.9M | $7.3M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $162.1M | $177.3M | $193.7M | $157.3M | $157.7M | |
Long-Term Debt | $165.8M | $160.5M | $135.1M | $135.5M | $124.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $394.6M | $389.9M | $374.8M | $336.9M | $324.5M | |
Common Stock | $733K | $739K | $766K | $772K | $786K | |
Other Common Equity Adj | -$71.4M | -$66M | -$78.9M | -$70M | -$79.5M | |
Common Equity | $757.6M | $695.8M | $689.6M | $709.5M | $680.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $757.6M | $695.8M | $689.6M | $709.5M | $680.7M | |
Total Liabilities and Equity | $1.2B | $1.1B | $1.1B | $1B | $1B | |
Cash and Short Terms | $72M | $52.9M | $42M | $47.1M | $65.4M | |
Total Debt | $183.5M | $178.8M | $152.9M | $136.1M | $125.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $54.5M | $39.2M | $15.8M | $24.1M | $66.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $123.1M | $124.7M | $163.4M | $134.9M | $109.5M | |
Inventory | $174.3M | $180.9M | $196.3M | $210.2M | $215.7M | |
Prepaid Expenses | $17.2M | $20.2M | -- | -- | -- | |
Other Current Assets | -- | -- | $18.1M | $35.2M | $21.6M | |
Total Current Assets | $419.5M | $434.5M | $450.4M | $470.2M | $487.7M | |
Property Plant And Equipment | $397.7M | $356.3M | $330M | $302.9M | $286.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $76.6M | $76.2M | $79.6M | $69.8M | $70.1M | |
Other Intangibles | $200.7M | $180.6M | $165.7M | $148.7M | $122.2M | |
Other Long-Term Assets | $5.5M | $4.8M | $4.6M | $2.7M | $3.2M | |
Total Assets | $1.1B | $1.1B | $1.1B | $1B | $990.7M | |
Accounts Payable | $50M | $60.7M | $73.5M | $57.1M | $49.9M | |
Accrued Expenses | $16.8M | $18.2M | $16.4M | $18.5M | $16.1M | |
Current Portion Of Long-Term Debt | $17.8M | $44M | $527K | $620K | $620K | |
Current Portion Of Capital Lease Obligations | $7.2M | $6.1M | $6.5M | $6.7M | $7.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $161.1M | $204.8M | $168.6M | $141.9M | $142.5M | |
Long-Term Debt | $170.1M | $134.8M | $138.5M | $135.6M | $124.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $392.3M | $389.9M | $354.6M | $323.5M | $307.3M | |
Common Stock | $738K | $746K | $771K | $785K | $805K | |
Other Common Equity Adj | -$72.9M | -$65.2M | -$74.8M | -$73M | -$74M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $732.2M | $688.1M | $695.5M | $692.3M | $683.4M | |
Total Liabilities and Equity | $1.1B | $1.1B | $1.1B | $1B | $990.7M | |
Cash and Short Terms | $54.5M | $39.2M | $15.8M | $24.1M | $66.8M | |
Total Debt | $187.9M | $178.8M | $139M | $136.2M | $125.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$468.4M | -$64M | -$9.5M | $12.9M | -$11.3M | |
Depreciation & Amoritzation | $98.5M | $80.7M | $67.3M | $60.8M | $54.7M | |
Stock-Based Compensation | $8.4M | $7.9M | $6.9M | $7M | $8.7M | |
Change in Accounts Receivable | $63.9M | -$24.4M | -$35.4M | $17.1M | $5.2M | |
Change in Inventories | $17.6M | -$10.3M | -$17.4M | -$19.8M | -$14.7M | |
Cash From Operations | $132.8M | $7.2M | $32.9M | $56.6M | $45.9M | |
Capital Expenditures | $12.7M | $17.5M | $20.3M | $30.7M | $37.5M | |
Cash Acquisitions | -- | -- | -$8.1M | -- | -- | |
Cash From Investing | -$3.7M | -$6.6M | -$22.7M | -$25.6M | $2.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $72.2M | $147.9M | $10.1M | $35.8M | $22.7M | |
Long-Term Debt Repaid | -$133.4M | -$158.1M | -$29.3M | -$53.6M | -$34.2M | |
Repurchase of Common Stock | -$2.7M | -$1.6M | -$1M | -$8.8M | -$16.8M | |
Other Financing Activities | -$1M | -$7.8M | -$105K | -$128K | -$1.2M | |
Cash From Financing | -$65M | -$19.6M | -$20.3M | -$26.7M | -$29.5M | |
Beginning Cash (CF) | $8.5M | $72M | $52.9M | $42M | $47.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $64M | -$19M | -$10.2M | $4.3M | $19.1M | |
Ending Cash (CF) | $72M | $52.9M | $42M | $47.1M | $65.4M | |
Levered Free Cash Flow | $120M | -$10.3M | $12.6M | $25.9M | $8.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$15.8M | -$9.4M | $2.2M | -$13.4M | $3.2M | |
Depreciation & Amoritzation | $21.5M | $17.8M | $15.3M | $14.2M | $12M | |
Stock-Based Compensation | $2.8M | $1.8M | $1.6M | $1.8M | $1.8M | |
Change in Accounts Receivable | -$10.7M | -$9.1M | -$745K | $1.6M | $12.4M | |
Change in Inventories | -$3.9M | -$13.1M | -$12.8M | -$8.9M | $237K | |
Cash From Operations | -$8.4M | -$10.7M | -$5.9M | -$11.4M | $9.3M | |
Capital Expenditures | $4.1M | $2.9M | $6.6M | $10.1M | $9.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.4M | -$2.1M | -$6.4M | -$7.8M | -$7K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $147.2M | $367K | $27.9M | $1.9M | $170K | |
Long-Term Debt Repaid | -$144.4M | -$532K | -$40.3M | -$2M | -$341K | |
Repurchase of Common Stock | -$1.5M | -$990K | -$1.9M | -$2.6M | -$7.8M | |
Other Financing Activities | -$8M | -$68K | -$21K | -$954K | -$6K | |
Cash From Financing | -$6.6M | -$1.2M | -$14.4M | -$3.7M | -$8M | |
Beginning Cash (CF) | $72M | $52.9M | $42M | $47.1M | $65.4M | |
Foreign Exchange Rate Adjustment | -$111K | $320K | $478K | -$178K | $132K | |
Additions / Reductions | -$17.4M | -$14M | -$26.7M | -$22.9M | $1.3M | |
Ending Cash (CF) | $54.5M | $39.2M | $15.8M | $24.1M | $66.8M | |
Levered Free Cash Flow | -$12.5M | -$13.6M | -$12.5M | -$21.5M | $137K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$79.2M | -$57.6M | $2M | -$2.6M | $5.3M | |
Depreciation & Amoritzation | $93.7M | $77M | $64.8M | $59.7M | $52.5M | |
Stock-Based Compensation | $10.1M | $6.9M | $6.6M | $7.1M | $8.8M | |
Change in Accounts Receivable | $48.6M | -$22.8M | -$27.1M | $19.5M | $16M | |
Change in Inventories | $29M | -$19.5M | -$17.1M | -$15.9M | -$5.6M | |
Cash From Operations | $118.9M | $4.9M | $37.7M | $51.1M | $66.5M | |
Capital Expenditures | $11M | $16.3M | $24M | $34.2M | $36.6M | |
Cash Acquisitions | -- | -- | -$8.1M | -- | -- | |
Cash From Investing | -$4M | -$6.3M | -$27.1M | -$27M | $10.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $147.2M | $1M | $37.6M | $9.8M | $21M | |
Long-Term Debt Repaid | -$220.7M | -$14.2M | -$69M | -$15.4M | -$32.5M | |
Repurchase of Common Stock | -$1.6M | -$1.1M | -$1.9M | -$9.5M | -$22M | |
Other Financing Activities | -$9M | $102K | -$58K | -$1.1M | -$230K | |
Cash From Financing | -$84M | -$14.2M | -$33.4M | -$16M | -$33.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $30.8M | -$15.6M | -$22.8M | $8.1M | $43.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $107.9M | -$11.4M | $13.7M | $17M | $30M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$15.8M | -$9.4M | $2.2M | -$13.4M | $3.2M | |
Depreciation & Amoritzation | $21.5M | $17.8M | $15.3M | $14.2M | $12M | |
Stock-Based Compensation | $2.8M | $1.8M | $1.6M | $1.8M | $1.8M | |
Change in Accounts Receivable | -$10.7M | -$9.1M | -$745K | $1.6M | $12.4M | |
Change in Inventories | -$3.9M | -$13.1M | -$12.8M | -$8.9M | $237K | |
Cash From Operations | -$8.4M | -$10.7M | -$5.9M | -$11.4M | $9.3M | |
Capital Expenditures | $4.1M | $2.9M | $6.6M | $10.1M | $9.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.4M | -$2.1M | -$6.4M | -$7.8M | -$7K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $147.2M | $367K | $27.9M | $1.9M | $170K | |
Long-Term Debt Repaid | -$144.4M | -$532K | -$40.3M | -$2M | -$341K | |
Repurchase of Common Stock | -$1.5M | -$990K | -$1.9M | -$2.6M | -$7.8M | |
Other Financing Activities | -$8M | -$68K | -$21K | -$954K | -$6K | |
Cash From Financing | -$6.6M | -$1.2M | -$14.4M | -$3.7M | -$8M | |
Beginning Cash (CF) | $72M | $52.9M | $42M | $47.1M | $65.4M | |
Foreign Exchange Rate Adjustment | -$111K | $320K | $478K | -$178K | $132K | |
Additions / Reductions | -$17.4M | -$14M | -$26.7M | -$22.9M | $1.3M | |
Ending Cash (CF) | $54.5M | $39.2M | $15.8M | $24.1M | $66.8M | |
Levered Free Cash Flow | -$12.5M | -$13.6M | -$12.5M | -$21.5M | $137K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.